CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome

Stefan Heinrichs, Jason N. Berman, Taylor M. Ortiz, Steven M. Kornblau, Donna S. Neuberg, Elihu H. Estey, A. Thomas Look

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)
Original languageEnglish
Pages (from-to)83-86
Number of pages4
JournalBritish Journal of Haematology
Volume130
Issue number1
DOIs
Publication statusPublished - Jul 2005
Externally publishedYes

ASJC Scopus Subject Areas

  • Hematology

Keywords

  • CD34
  • HOX
  • Myelodysplastic syndrome

Fingerprint

Dive into the research topics of 'CD34+ cell selection is required to assess HOXA9 expression levels in patients with myelodysplastic syndrome'. Together they form a unique fingerprint.

Cite this